SCHEMBL24818239

SCHEMBL24818239

CC(C)(C)OC(=O)NC1(CN2CCC2)CC1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PPIA P62937 1/20 0.39
NPFFR1 Q9GZQ6 1/20 0.37
NPFFR2 Q9Y5X5 1/20 0.37
DRD2 P14416 6/20 0.36
CTSK P43235 2/20 0.36
CTSL P07711 2/20 0.36
CTSB P07858 1/20 0.36
CACNA1H O95180 1/20 0.36
HDAC4 P56524 1/20 0.35
P2RX7 Q99572 1/20 0.35
CHRM2 P08172 2/20 0.34
CHRM4 P08173 2/20 0.34
CHRM5 P08912 2/20 0.34
CHRM1 P11229 2/20 0.34
CHRM3 P20309 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
MEN1 O00255 1/20 0.33
MAPK1 P28482 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23692608 0.97 PPIA (0.39) PPIANPFFR1NPFFR2DRD2CTSK
SCHEMBL31491350 0.87 SMN1; SMN2 (0.43) PPIADRD2CTSKCTSLCTSB
SCHEMBL24815894 0.82 KMT2A (0.35) PPIADRD2CTSKCTSLCACNA1H
SCHEMBL2869065 0.80 DRD2 (0.37) PPIANPFFR1NPFFR2DRD2CTSK
SCHEMBL20069700 0.80 CACNA1H (0.37) PPIANPFFR1NPFFR2DRD2CTSK
SCHEMBL31560797 0.78 CACNA1H (0.34) NPFFR1NPFFR2DRD2CTSKCTSL
SCHEMBL20147479 0.77 CTSL (0.35) PPIANPFFR1NPFFR2DRD2CTSK
SCHEMBL14173595 0.76 KMT2A (0.38) PPIACTSKCTSLP2RX7MEN1
SCHEMBL56916 0.76 TDP1 (0.41) PPIADRD2CTSKCTSLP2RX7
SCHEMBL7609264 0.75 MEN1 (0.37) PPIACTSKCTSLP2RX7MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025074305-A1 N-(1-(AMINOMETHYL)CYCLOPROPYL)(ARYL OR HETEROARYL) CARBOXAMIDE DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2025-04-10 WO disclosed
WO-2022268230-A1 COMPOUND AS KIF18A INHIBITOR 杭州英创医药科技有限公司 2022-12-29 WO disclosed